Why is Emmessar Biotech falling/rising?

As of 10-Oct, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.50, reflecting a decrease of 0.38, or 1.19%. The stock has been underperforming, having fallen for the last two days with a total decline of 1.22%. In the past week, it has experienced a significant drop of 5.97%, while over the last month, it has shown a positive return of 14.55%. Despite these gains in the longer term, the stock is down 31.97% year-to-date and 29.83% over the past year. Notably, the stock's delivery volume has increased significantly, indicating rising investor participation, although it is currently underperforming its sector by 1.58%. There is no information available regarding positive or negative factors impacting the stock.
Broader Market Context: The stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.59% over the past week. While Emmessar Biotech has shown some recovery in the past month, its year-to-date and one-year returns are significantly lower than the Sensex's positive performance of 5.58% and 1.09%, respectively. This broader market context highlights the challenges faced by Emmessar Biotech, as it struggles to keep pace with market trends despite some positive momentum in the short term.